Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Editorial & Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Caixin Weekly Sneak Peek
Topics
Asia New Vision Forum
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
News Graphics
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
staff reporters wang jing
Evergrande Becomes Troubled Vanke's Fourth Largest Shareholder
Shenzhen Bourse Queries Vanke's Hostile Suitors
Did a Chinese Insurer Cross the Investor Line?
Among Millions Afflicted, Too Few to Treat
Policy Makers Mull Cutting Prices of Drugs for Rare Diseases
Drug Maker to Stop Selling Medicine for Multiple Sclerosis in August
Firm Angling for Vanke Takeover Touts Its Financial Strength
Southern City Offers Factories Subsidies for Installing Robots
Corruption Scandals Hit Science Officials in Guangdong
HNA Struggles to Make Dreams of Dominance Come True
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通